Quality of Nuchal Translucency Measurements Correlates with Broader Aspects of Program Rigor and Culture of Excellence

被引:3
作者
Evans, Mark I. [1 ,2 ]
Krantz, David A. [3 ]
Hallahan, Terrence [3 ]
Sherwin, John [3 ]
Britt, David W. [4 ]
机构
[1] Comprehens Genet, New York, NY 10065 USA
[2] Mt Sinai Sch Med, Dept Obstet & Gynecol, New York, NY USA
[3] NTD Labs Perkin Elmer, Melville, NY USA
[4] Univ Louisville, Ctr Hlth Promot & Prevent Sci, Dept Hlth & Sports Sci, Louisville, KY 40292 USA
关键词
Nuchal translucency screening; Quality control; Nasal bone measurements; Organizational culture; PERFORMANCE; CARE;
D O I
10.1159/000346418
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Introduction:To determine if nuchal translucency (NT) quality correlates with the extent to which clinics vary in rigor and quality control. Methods: We correlated NT performance quality (bias and precision) of 246,000 patients with two alternative measures of clinic culture - % of cases for whom nasal bone (NB) measurements were performed and % of requisitions correctly filled for race-ethnicity and weight. Results: When requisition errors occurred in <5% of cases, the average MoM (multiple of the median) was 0.97. When >5% (33%), the curve lowered to 0.93 MoM (p < 0.001) with both bias and precision of measurements impaired. Likewise, for centers with NB >90%, MoM was 0.99 compared to those <10% at 0.93 (p < 0.001). Precision and bias were highly correlated (p < 0.001). Conclusions: Rigor in NT measurements has improved, but the discussion has been confined to individuals. Progressive educational and remediation strategies need to expand to a second dimension clinics themselves. Cross-clinic variation in NT quality exists independent of individual variation in NT quality, and two divergent indices of program rigor are associated with NT quality. Quality control must be program wide, and to effect continued improvement in the quality of NT results across time, the cultures of clinics must become a target for intervention. Copyright (C) 2013 S. Karger AG, Basel
引用
收藏
页码:230 / 234
页数:5
相关论文
共 22 条
[1]   Aneuploidy screening: a position statement from a committee on behalf of the Board of the International Society for Prenatal Diagnosis, January 2011 [J].
Benn, Peter ;
Borrell, Antoni ;
Crossley, Jenny ;
Cuckle, Howard ;
Dugoff, Lorraine ;
Gross, Susan ;
Johnson, Jo-ann ;
Maymon, Ron ;
Odibo, Anthony ;
Schielen, Peter ;
Spencer, Kevin ;
Wright, Dave ;
Yaron, Yuval .
PRENATAL DIAGNOSIS, 2011, 31 (06) :519-522
[2]  
Britt DW, 2000, PRENATAL DIAGNOSIS G
[3]  
Britt DW, 1991, HDB CLIN SOCIOLOGY, P259
[4]  
Cohen A.B., 2004, Technology in American Health Care
[5]   Nuchal Translucency Quality Monitoring The Transition From Research to Clinical Care [J].
D'Alton, Mary E. .
OBSTETRICS AND GYNECOLOGY, 2010, 116 (04) :806-807
[6]   Context, composition and heterogeneity: Using multilevel models in health research [J].
Duncan, C ;
Jones, K ;
Moon, G .
SOCIAL SCIENCE & MEDICINE, 1998, 46 (01) :97-117
[7]  
EHRMEYER SS, 1990, CLIN CHEM, V36, P1736
[8]   Impact of nuchal translucency credentialing by the FMF, the NTQR or both on screening distributions and performance [J].
Evans, M. I. ;
Krantz, D. A. ;
Hallahan, T. W. ;
Sherwin, J. .
ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2012, 39 (02) :181-184
[9]   Overcoming militant mediocrity [J].
Evans, Mark I. .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2008, 198 (06) :656-661
[10]   Nuchal translucency measurements for first-trimester screening: The 'Price' of inaccuracy [J].
Evans, Mark I. ;
Van Decruyes, Hilde ;
Nicolaides, Kypros H. .
FETAL DIAGNOSIS AND THERAPY, 2007, 22 (06) :401-404